147 related articles for article (PubMed ID: 16287555)
1. [Trends of non-steroidal anti-inflammatory drugs use in Spain, 1990 through 2003].
de Abajo FJ; del Pozo JG; del Pino A
Aten Primaria; 2005 Nov; 36(8):424-33. PubMed ID: 16287555
[TBL] [Abstract][Full Text] [Related]
2. The outpatient utilization of non-steroidal anti-inflammatory drugs in South Bačka District, Serbia.
Calasan J; Mijatović V; Horvat O; Varga J; Sabo A; Stilinović N
Int J Clin Pharm; 2011 Apr; 33(2):246-51. PubMed ID: 21744192
[TBL] [Abstract][Full Text] [Related]
3. Future projections of opioid use and cost in patients with chronic osteoarthritis pain in Spain.
Rejas-Gutierrez J; Sicras-Mainar A; Darbà J
Ther Adv Musculoskelet Dis; 2021; 13():1759720X211010599. PubMed ID: 33995603
[TBL] [Abstract][Full Text] [Related]
4. [Use of antihypertensive drugs in Spain (1995-2001)].
García del Pozo J; Ramos Sevillano E; de Abajo FJ; Mateos Campos R
Rev Esp Cardiol; 2004 Mar; 57(3):241-9. PubMed ID: 15056428
[TBL] [Abstract][Full Text] [Related]
5. [Prescription of cyclooxygenase-2 inhibitors: an intervention strategy in primary care].
Rosich I; Soler M; Tomás R; Crusat D
Gac Sanit; 2005; 19(3):229-34. PubMed ID: 15960956
[TBL] [Abstract][Full Text] [Related]
6. [Trends in antibiotic consumption in Spain, 1985-2000].
Lázaro Bengoa E; Madurga Sanz M; de Abajo Iglesias FJ
Med Clin (Barc); 2002 Apr; 118(15):561-8. PubMed ID: 12015944
[TBL] [Abstract][Full Text] [Related]
7. Pattern of non-steroidal anti-inflammatory drug use in Australia 1990-1994. A report from the Drug Utilization Sub-Committee of the Pharmaceutical Benefits Advisory Committee.
McManus P; Primrose JG; Henry DA; Birkett DJ; Lindner J; Day RO
Med J Aust; 1996 May; 164(10):589-92. PubMed ID: 8637461
[TBL] [Abstract][Full Text] [Related]
8. [Use of specific drugs for Alzheimer's disease].
Villar Fernández I; Rabaneque Hernández MJ; Armesto Gómez J; García Arilla E; Izuel Rami M
Neurologia; 2007 Jun; 22(5):275-84. PubMed ID: 17508301
[TBL] [Abstract][Full Text] [Related]
9. [Use of antihypertensive drugs in Spain, 1985-1995].
Prieto M; de Abajo FJ; Montero D; Martín-Serrano G; Madurga M; Palop R
Med Clin (Barc); 1998 Feb; 110(7):247-53. PubMed ID: 9562948
[TBL] [Abstract][Full Text] [Related]
10. Quality of non-steroidal anti-inflammatory drug prescribing in Croatia (Rijeka) and Sweden (Stockholm).
Vlahovic-Palcevski V; Wettermark B; Bergman U
Eur J Clin Pharmacol; 2002 Jun; 58(3):209-14. PubMed ID: 12107607
[TBL] [Abstract][Full Text] [Related]
11. [Outpatient utilization of non-steroidal anti-inflammatory drugs in three largest municipalities in South Backa district].
Horvat O; Mijatović V; Čalasan J; Sabo A
Srp Arh Celok Lek; 2012; 140(5-6):339-43. PubMed ID: 22826988
[TBL] [Abstract][Full Text] [Related]
12. Cost-efficiency of nonsteroidal anti-inflammatory drug prescribing in Zagreb, Croatia.
Vukusić I; Stimac D; Culig J
Coll Antropol; 2005 Jun; 29(1):143-7. PubMed ID: 16117313
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of antibiotic use in the Community of Valencia (2000-2002)].
Pedrera V; Schwarz H; Pascual de la Torre M; Gil-Guillén V; Orozco D; Canelles JM
Enferm Infecc Microbiol Clin; 2004; 22(7):385-9. PubMed ID: 15355768
[TBL] [Abstract][Full Text] [Related]
14. Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors.
Fischer MA; Schneeweiss S; Avorn J; Solomon DH
N Engl J Med; 2004 Nov; 351(21):2187-94. PubMed ID: 15548779
[TBL] [Abstract][Full Text] [Related]
15. [Rational use of non-steroidal anti-inflammatory drugs in primary care].
Romo Avilés C; Martín Calero MJ; Motilva Sánchez V; Alarcón de la Lastra Romero C
Aten Primaria; 1998; 22(3):177-80. PubMed ID: 9741172
[TBL] [Abstract][Full Text] [Related]
16. Trends in celecoxib and etoricoxib prescribing following removal of prior authorization requirement in Spain.
Carracedo-Martínez E; Pia-Morandeira A; Figueiras A
J Clin Pharm Ther; 2017 Apr; 42(2):185-188. PubMed ID: 27982453
[TBL] [Abstract][Full Text] [Related]
17. The pattern of use of non-steroidal anti-inflammatory drugs (NSAIDs) from 1997 to 2005: a nationwide study on 4.6 million people.
Fosbøl EL; Gislason GH; Jacobsen S; Abildstrom SZ; Hansen ML; Schramm TK; Folke F; Sørensen R; Rasmussen JN; Køber L; Madsen M; Torp-Pedersen C
Pharmacoepidemiol Drug Saf; 2008 Aug; 17(8):822-33. PubMed ID: 18383428
[TBL] [Abstract][Full Text] [Related]
18. Antidiabetic medications use trends in an Andalusian region from 2001 to 2014.
López-Sepúlveda R; García Lirola MÁ; Espínola García E; Jurado Martínez JM; Martín Sances S; Anaya Ordóñez S; Cabeza Barrera J
Prim Care Diabetes; 2017 Jun; 11(3):254-264. PubMed ID: 28126469
[TBL] [Abstract][Full Text] [Related]
19. Nonsteroidal anti-inflammatory drug usage and gastrointestinal outcomes in the Republic of Serbia.
Petric M; Tasic L; Sukljevic S
J Pain Palliat Care Pharmacother; 2009; 23(1):40-7. PubMed ID: 19296354
[TBL] [Abstract][Full Text] [Related]
20. Nonaspirin Nonsteroidal Antiinflammatory Drug Use in the Nordic Countries from a Cardiovascular Risk Perspective, 2000-2016: A Drug Utilization Study.
Kristensen KB; Karlstad Ø; Martikainen JE; Pottegård A; Wastesson JW; Zoega H; Schmidt M
Pharmacotherapy; 2019 Feb; 39(2):150-160. PubMed ID: 30636337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
